SARS-CoV-2: The viral shedding vs infectivity dilemma

No Thumbnail Available
File version
Author(s)
Widders, Arabella
Broom, Alex
Broom, Jennifer
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with infectivity. The duration of quarantine required after clinical recovery to definitively prevent transmission is therefore uncertain. In addition, asymptomatic and presymptomatic transmission may occur, and infectivity may be highest early after onset of symptoms, meaning that contact tracing, isolation of exposed individuals and social distancing are essential public health measures to prevent further spread. This review aimed to summarise the evidence around viral shedding vs infectivity of SARS-CoV-2.

Journal Title

Infection, Disease & Health

Conference Title
Book Title
Edition
Volume

25

Issue

3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Health services and systems

Public health

Persistent link to this record
Citation

Widders, A; Broom, A; Broom, J, SARS-CoV-2: The viral shedding vs infectivity dilemma, Infection, Disease & Health, 2020, 25 (3), pp. 210-215

Collections